Vaxchora
Phase 3Small molecule
Vaxchora is one of 4 small molecule programs targeting Typhoid. It is currently in Phase 3.
1
Indications
4
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
3 competitors in Typhoid
#DrugCompanyPhaseTrials
1Cipro
BayerPhase 2
Vivotif Typhoid Oral Vaccine
UUniversity of Maryland, Baltimore
Phase 3
Vaxchora
UUniversity of Maryland, Baltimore
Phase 3
Salmonella Typhimurium
MMasonic Cancer Center, University of Minnesota
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Donor1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Vaxchora. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details